| 发明名称 |
COMBINATION OF ANTI-CTLA4 ANTIBODY WITH DIVERSE THERAPEUTIC REGIMENS FOR THE SYNERGISTIC TREATMENT OF PROLIFERATIVE DISEASES. |
| 摘要 |
<p>Compositions and methods are disclosed which are useful of the treatment and prevention of proliferative disorders. Such Compositions comprise inter alia an anti-CTLA-4 agent, e.g. ipilimumab or tremelimumab in combination with other chemotherapeutic agents such as dasatinib, imatinib, paclitaxel, gemcitabine, cisplatin or etoposide.</p> |
| 申请公布号 |
MX2012000851(A) |
申请公布日期 |
2012.06.08 |
| 申请号 |
MX20120000851 |
申请日期 |
2009.10.29 |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY.* |
发明人 |
FRANCIS Y. LEE;MARIA JURE-KUNKEL |
| 分类号 |
C07K16/28;A61K31/337;A61K31/385;A61K31/506;A61K33/24;A61K39/395;A61K45/06;A61P35/00;C07K16/18 |
主分类号 |
C07K16/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
